Compagnie Lombard Odier SCmA Acquires Shares of 30,370 Aflac Incorporated (NYSE:AFL)

Compagnie Lombard Odier SCmA purchased a new position in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 30,370 shares of the financial services provider's stock, valued at approximately $3,377,000.

Other hedge funds have also added to or reduced their stakes in the company. Allen Mooney & Barnes Investment Advisors LLC grew its stake in Aflac by 1.8% during the 1st quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 65,541 shares of the financial services provider's stock valued at $7,288,000 after purchasing an additional 1,151 shares during the last quarter. First United Bank & Trust grew its holdings in Aflac by 29.8% in the first quarter. First United Bank & Trust now owns 519 shares of the financial services provider's stock valued at $58,000 after purchasing an additional 119 shares during the period. Simon Quick Advisors LLC raised its stake in shares of Aflac by 7.0% during the 1st quarter. Simon Quick Advisors LLC now owns 4,893 shares of the financial services provider's stock worth $544,000 after buying an additional 322 shares during the period. Capital Advisory Group Advisory Services LLC lifted its position in shares of Aflac by 16.4% during the 1st quarter. Capital Advisory Group Advisory Services LLC now owns 3,325 shares of the financial services provider's stock valued at $370,000 after buying an additional 469 shares in the last quarter. Finally, Transform Wealth LLC purchased a new position in shares of Aflac during the 1st quarter valued at approximately $252,000. 67.44% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Aflac

In other Aflac news, Director Masatoshi Koide sold 37,000 shares of the company's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the transaction, the director now owns 70,992 shares in the company, valued at $7,496,045.28. This represents a 34.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Arthur Reginald Collins sold 2,750 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total value of $290,675.00. Following the transaction, the director now owns 6,728 shares in the company, valued at $711,149.60. The trade was a 29.01% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,750 shares of company stock worth $4,304,295 over the last ninety days. Corporate insiders own 0.90% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Piper Sandler upped their price objective on shares of Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Morgan Stanley upped their price objective on shares of Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Monday, May 19th. Keefe, Bruyette & Woods lifted their target price on shares of Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research note on Wednesday, May 7th. Wells Fargo & Company lifted their target price on shares of Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a research note on Tuesday, May 6th. Finally, Barclays lifted their target price on shares of Aflac from $95.00 to $96.00 and gave the stock an "underweight" rating in a research note on Thursday, May 1st. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Aflac presently has a consensus rating of "Hold" and an average target price of $104.93.

Aflac Trading Up 1.3%

Shares of NYSE AFL traded up $1.31 during trading on Thursday, reaching $102.66. The stock had a trading volume of 1,800,578 shares, compared to its average volume of 2,109,931. Aflac Incorporated has a fifty-two week low of $86.46 and a fifty-two week high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The business's 50-day moving average price is $104.99 and its 200-day moving average price is $105.75. The company has a market cap of $55.50 billion, a P/E ratio of 10.69, a PEG ratio of 3.24 and a beta of 0.82.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The firm had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. Aflac had a net margin of 28.76% and a return on equity of 16.20%. The company's quarterly revenue was down 37.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.66 earnings per share. On average, equities research analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were paid a $0.58 dividend. This represents a $2.32 annualized dividend and a dividend yield of 2.26%. The ex-dividend date was Wednesday, May 21st. Aflac's payout ratio is currently 36.25%.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.